Skip to main content
. 2022 Jun 21;14(7):1314. doi: 10.3390/pharmaceutics14071314

Figure 2.

Figure 2

In vitro release behavior of IMP301 and DOXIL. (a) Continuous wave ultrasound (CW)- and FUS (pulsed wave, PW)-triggered release of IMP301 (dark gray) and DOXIL (light gray); n = 3. TEM image of IMP301 (b) before ultrasound irradiation and (c) after ultrasound irradiation.